William Bauscher, OD in Springfield, VA - Optometrist

William Bauscher, OD is a Optometrist based in Springfield, Virginia. William Bauscher is licensed to practice in Virginia (license number 0601002078) and his current practice location is 6636 Springfield Mall, Springfield, Virginia. He can be reached at his office (for appointments etc.) via phone at (703) 922-4111.

NPI number for William Bauscher is 1407938517 and his current mailing address is 11103 West Ave, Suite 6, San Antonio, Texas. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1407938517.

Contact Information

	William Bauscher, OD
	6636 Springfield Mall, Springfield, VA 22150-1712
	(703) 922-4111
	(703) 924-0610

Healthcare Provider's Profile

Full Name	William Bauscher
Gender	Male
Speciality	Optometrist
Location	6636 Springfield Mall, Springfield, Virginia
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1407938517
Provider Enumeration Date: 10/19/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for William Bauscher such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1407938517	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
152W00000X	Optometrist	0601002078 (Virginia)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. William Bauscher is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
William Bauscher, OD 11103 West Ave, Suite 6, San Antonio, TX 78213-1370 Ph: (210) 524-6509	William Bauscher, OD 6636 Springfield Mall, Springfield, VA 22150-1712 Ph: (703) 922-4111

News Archive

Under the microscope: Ryan's plans for Medicare, Medicaid and the federal budget

News outlets examine how Medicare and Medicaid fare in the budget blueprint advanced by Rep. Paul Ryan, R-Wis., chairman of the House Budget Committee and GOP presidential hopeful Mitt Romney's vice presidential pick.

Two researchers win Humanity in Science prize for developing new antimalarial drug production methods

Prof. Dr. Peter H. Seeberger, a director at the Max Planck Institute of Colloids and Interfaces in Potsdam and a professor of chemistry at Freie Universität Berlin, and Prof. Dr.-Ing. Andreas Seidel-Morgenstern, a director at the Max Planck Institute for Dynamics of Complex Technical Systems in Magdeburg and a professor of chemical engineering at the Otto-von Guericke-University in Magdeburg, won the Humanity in Science prize for their groundbreaking work in developing new production methods for antimalarial drugs.

Japanese study finds proton beam therapy safe and effective for Stage I inoperable NSCLC

Proton beam therapy is safe and effective and may be superior to other conventional treatments for Stage I inoperable non-small cell lung cancer (NSCLC) patients, according to a study in the October issue of the International Journal of Radiation Oncology•Biology•Physics, the official journal of the American Society for Radiation Oncology (ASTRO).

Large public-private partnership announced to speed progress against NTDs

Thirteen pharmaceutical companies; the governments of the U.S., U.K. and United Arab Emirates; the Bill & Melinda Gates Foundation; the WHO; the World Bank; the Drugs for Neglected Diseases initiative (DNDi); and other global health organizations "announced a new, coordinated push to accelerate progress toward eliminating or controlling 10 neglected tropical diseases (NTDs) by the end of the decade," according to a press release from Global Health Strategies.

Highland Therapeutics subsidiary reports positive HLD-200 Phase-1 results in ADHD patients

Highland Therapeutics, Inc., a specialty pharmaceutical company based in the MaRS Discovery District in Toronto, today announced that its wholly owned subsidiary has generated positive Phase-1 results for HLD-200 - a novel formulation of methylphenidate being developed to treat the symptoms associated with Attention-Deficit/Hyperactivity Disorder.

Optometrist in Springfield, VA

Grace Chang, Od Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 6575n Frontier Dr, Springfield, VA 22150 Phone: 703-971-7722 Fax: 703-971-1724
Vincent Bertomeu, Od, Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 6506 Loisdale Rd, Ste 102, Springfield, VA 22150 Phone: 703-719-9110 Fax: 703-719-9040
Dr. Nava Ezra, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 6501 Loisdale Court, Springfield, VA 22150 Phone: 703-922-1000
Dr. Jeannette Lucille Liu, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 6701 Loisdale Rd, Suite S, Springfield, VA 22150 Phone: 703-719-5455
Minh-tam Nguyen, Optometrist Medicare: Medicare Enrolled Practice Location: 8424 Old Keene Mill Rd, Springfield, VA 22152 Phone: 703-569-6611
My Eye Dr. Optometrist Medicare: Medicare Enrolled Practice Location: 6406 Springfield Plz, Springfield, VA 22150 Phone: 703-451-4577 Fax: 703-451-8549
Michael J. Davidson, O.d., P.c. Optometrist Medicare: Medicare Enrolled Practice Location: 8350 Traford Ln, Fl 2, Springfield, VA 22152 Phone: 703-569-6363

William Bauscher, OD - Optometrist in Springfield, VA